TAK Takeda Pharmaceutical Company Limited

NYSE
$18.64

Takeda Pharmaceutical Company Limited (TAK) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Bearish Selling ran elevated versus TAK's own trailing one-year pace, with 19% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 13 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
13
20 transactions
Purchases
$0
0 shares
Sales
$13.1M
749,336 shares
Net activity
-$13.1M
purchases less sales

How much of that selling was preplanned? 19% planned / 81% discretionary

10b5-1 plan sales $2.5M 2 transactions · 135,842 shares
Discretionary sales $10.6M 18 transactions · 613,494 shares

Largest single sale: $2.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Duprey Lauren Rusckowski Chief Transformation Officer Sell 34,535 $18.54 $640.3K 191,522 −15.3% of holding
Plump Andrew Stewart President, R&D Sell 10b5-1 116,191 $18.49 $2.1M 145,465 −44.4% of holding
Plump Andrew Stewart President, R&D Sell 10b5-1 19,651 $18.49 $363.3K 261,656 −7% of holding
Greenway Nicola Deidre Petal Chief Human Resources Officer Sell 12,980 $18.11 $235.1K 40,049 −24.5% of holding
Shannon Elaine Mary Pres., Global Supply & Quality Sell 20,363 $17.55 $357.4K 67,311 −23.2% of holding
Plump Andrew Stewart President, R&D Sell 165,393 $17.10 $2.8M 766,569 −17.7% of holding
Kim Julie So-Young President and CEO Sell 89,090 $17.10 $1.5M 391,489 −18.5% of holding
Bitetti Teresa Marie President, OBU Sell 50,012 $17.10 $855.2K 252,010 −16.6% of holding
Duprey Lauren Rusckowski Chief Transformation Officer Sell 47,586 $17.10 $813.7K 226,057 −17.4% of holding
Greenway Nicola Deidre Petal 3 fills Chief Human Resources Officer Sell 41,377 $17.44 $721.6K 93,431 −30.7% of holding
Platford Giles Richard President, IBU Sell 31,083 $17.10 $531.5K 315,838 −9% of holding
Furney Natalie Anne Marie Global General Counsel Sell 30,868 $17.10 $527.8K 204,298 −13.1% of holding
Ricci Gabriele Chief Data & Tech. Officer Sell 25,088 $17.10 $429.0K 171,654 −12.8% of holding
Pignagnoli Agosti Marcello Head, Strat. & Port. Dev Sell 22,957 $17.10 $392.6K 176,977 −11.5% of holding
Pacheco Rhonda Janice President, U.S. Business Unit Sell 16,901 $17.10 $289.0K 182,507 −8.5% of holding
Farajallah Awny Samaan Botros Chief Medical Officer Sell 14,006 $17.10 $239.5K 116,177 −10.8% of holding
Ibrahim Ramy Riad Ahmed President, PDT BU Sell 7,277 $17.10 $124.4K 102,588 −6.6% of holding
Shannon Elaine Mary Pres., Global Supply & Quality Sell 3,978 $17.10 $68.0K 63,333 −5.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.